Matinas BioPharma Holdings, Inc. — Form D

Matinas BioPharma Holdings, Inc. of BEDMINSTER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-26. The offering totals $15.5M, of which $15.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Herbert A ConradDirectorBedminster, NJ
Stefano A FerrariDirectorBedminster, NJ
Roelof RongenDirectorDelray Beach, FL
James F ScibettaDirectorBedminster, NJ
Adam A SternDirectorBedminster, NJ
Abdel A FawzyExecutive OfficerBedminster, NJ
Gary A GaglioneExecutive OfficerBedminster, NJ
Jerome A JabbourExecutive OfficerBedminster, NJ
Douglas F KlingExecutive OfficerBedminster, NJ
Raphael J ManninoExecutive OfficerTampa, FL
Roelof RongenExecutive OfficerDelray Beach, FL
Robin SmithDirectorBEDMINSTER, NJ
Eric EndeDirectorBEDMINSTER, NJ
Jerome JabbourDirectorBEDMINSTER, NJ
Jerome JabbourExecutive OfficerBEDMINSTER, NJ
Evelyn D'AnDirectorBEDMINSTER, NJ
Keith KucinskiExecutive OfficerBEDMINSTER, NJ
Matthew WiklerDirectorBEDMINSTER, NJ
Natasha GiordanoDirectorHoboken, NJ
Jerome A JabbourDirectorBedminster, NJ
George BobotasExecutive OfficerBedminster, NJ
STEPHEN P HARRINGTONDirectorPLYMOUTH MEETING, PA
STEPHEN P HARRINGTONExecutive OfficerPLYMOUTH MEETING, PA

Other filings by this issuer (5)

FiledFormOfferingSold
2025-02-19D$3.3M$1.6M
2016-08-12D$8.0M$4.4M
2015-04-13D$10.0M$10.0M
2013-08-07D$15.0M$7.6M
2013-07-25D$385K$385K

More